Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Importance
Investigating associations between life course sleep duration and Parkinson’s disease (PD) may help clarify the role of sleep in early detection and/or prevention of PD.
Objective
To characterize life course sleep duration trajectories and their associations with PD risk and age at onset (AAO).
Design
Two ongoing online cohorts: Parkinson’s Progression Markers Initiative (PPMI)-Online (discovery; started in 2021) and Fox Insight (FI; validation; started in 2018).
Setting
Participants reported sleep duration across life stages, with PD-related follow-ups every three months.
Participants
A convenience sample of 5,660 individuals with PD and 10,245 without PD from PPMI-Online, and 1,929 participants with PD from FI.
Exposures
Self-reported sleep duration from ages 18 to 80+ in PPMI-Online and 12 to 66+ in FI. Latent class growth analysis (LCGA) identified sleep trajectories.
Main Outcomes and Measures
PD risk and AAO were assessed using logistic and linear regression, adjusting for demographics, lifestyle, comorbidities.
Results
The combined sample included 17,834 participants [age at sleep report 67.2±7.83 years; 9,735 (54.6%) female]. LCGA identified nine sleep trajectories in PPMI-Online, stable in early adulthood but diverging in midlife (stable, increasing, decreasing). Midlife sleep reductions (6-7 to ≤5-6 hours/day: OR = 1.90, 95% CI 1.61-2.24, P < .001; 7-8 to ≤6-7 hours/day: OR = 1.64, 95% CI 1.40-1.91, P < .001) and consistent short sleep (<=6 hours/day throughout adulthood: OR = 1.41, 95% CI 1.19-1.67, P < .001) demonstrated increased PD risk. Short sleep in early adulthood or midlife also had earlier AAO. The strongest effects were seen in those with ≤6 hours/day throughout adulthood (PPMI-Online: β = −2.45 years, 95% CI −3.33 to −1.56, P <.001) and those with a continuous decrease since adolescence (FI: β = −4.23 years, 95% CI −5.52 to −2.93, P < .001). These effects were independent of rapid eye movement sleep behavior disorders.
Conclusions and Relevance
Self-reported short sleep in early adulthood and midlife sleep reductions are associated with increased PD risk and earlier AAO. Self-perceived midlife sleep reduction may be a marker for future PD. Persons with chronic short sleep may be candidates for preventive intervention.
Key Points
Question: What is the relationship between life course sleep duration trajectories and the risk and age at onset of Parkinson’s disease (PD)?
Findings: In this cohort study including 7,589 participants with PD and 10,245 without PD, short sleep duration in early adulthood or decreasing sleep duration after age 50 were associated with an increased risk and earlier age at onset of PD.
Meaning: Short sleep duration over the life course, even in early adulthood (< 40 years), may contribute to risk of late-life PD; declining sleep duration after age 50 is a potential prodromal sign of PD.
